Results 221 to 230 of about 107,361 (347)

Continuous Vesicle Cycling in the Synaptic Terminal of Retinal Bipolar Cells [PDF]

, 1996
Leon Lagnado, Ana Gomis, Christy Job
openalex   +1 more source

Neurodegenerative and Neurodevelopmental Roles for Bulk Lipid Transporters VPS13A and BLTP2

Movement Disorders, EarlyView.
Abstract Background Bridge‐like lipid transfer proteins (BLTPs) mediate bulk lipid transport at membrane contact sites. Mutations in BLTPs are linked to both early‐onset neurodevelopmental and later‐onset neurodegenerative diseases, including movement disorders.
Sarah D. Neuman, Rajan S. Thakur, Scott J. Gratz, Kate M. O'Connor‐Giles, Arash Bashirullah   +4 more
wiley   +1 more source

Synapsin condensation controls synaptic vesicle sequestering and dynamics. [PDF]

Nat Commun, 2023
Hoffmann C, Rentsch J, Tsunoyama TA, Chhabra A, Aguilar Perez G, Chowdhury R, Trnka F, Korobeinikov AA, Shaib AH, Ganzella M, Giannone G, Rizzoli SO, Kusumi A, Ewers H, Milovanovic D.   +14 more
europepmc   +1 more source

Synaptic Vesicle Recycling in Cultured Cerebellar Granule Cells: Role of Vesicular Acidification and Refilling [PDF]

, 1997
Michael A. Cousin, David G. Nicholls
openalex   +1 more source

Paired Deep Brain Stimuli Elicit Short‐Term Facilitation in Globus Pallidus Interna and Subthalamic Nucleus

Movement Disorders, EarlyView.
Abstract Background Deep brain stimulation (DBS) elicits oscillatory local field potentials in patients with Parkinson's disease (PD) and other movement disorders. Greater knowledge about the fast dynamics of these neural responses could shed light on circuit pathophysiology and inform novel approaches to neuromodulation therapies.
Sarah Brinkerhoff, Arie Nakhmani, Alex Varghese, Cameron Gordon, Christopher L. Gonzalez, J. Nicole Bentley, Marshall T. Holland, Harrison C. Walker   +7 more
wiley   +1 more source

Endocytosis of VAMP is facilitated by a synaptic vesicle targeting signal. [PDF]

, 1996
Eric Grote, R B Kelly
openalex   +1 more source

Positron Emission Tomography Imaging in Clinical Trials for Parkinson's Disease: Applications of Metabolic Brain Network Approach

Movement Disorders, EarlyView.
ABSTRACT Neuroimaging with positron emission tomography (PET) has been instrumental in elucidating neurobiological mechanisms behind therapeutical trials in Parkinson's disease (PD). A variety of medical and neurosurgical interventions have been evaluated using many radioligands that reveal molecular basis for target engagement and brain responses in ...
Vijay Dhawan, Shichun Peng, Phoebe G. Spetsieris, David Eidelberg, Yilong Ma   +4 more
wiley   +1 more source

Defect in Synaptic Vesicle Precursor Transport and Neuronal Cell Death in KIF1A Motor Protein–deficient Mice

, 1998
Yoshiaki YONEKAWA, Akihiro Harada, Yasushi Okada, Takeshi Funakoshi, Yoshimitsu Kanai, Yosuke Takei, Sumio Terada, Tetsuo Noda, Nobutaka Hirokawa   +8 more
openalex   +1 more source

Redistribution of synaptic vesicles and their proteins in temperature-sensitive shibire(ts1) mutant Drosophila. [PDF]

, 1995
Jana van de Goor, Mani Ramaswami, R. W. Kelly   +2 more
openalex   +1 more source

Disease‐Modifying Trials in Treated Parkinson's Disease: “Stable Treated” Does Not Equate with Biological Stability

Movement Disorders, EarlyView.
Abstract Traditionally, clinical trials of putative disease‐modifying therapies in Parkinson's disease have enrolled untreated patients at the earliest clinical stages of their disease. Due to a number of challenges inherent with this approach, there has been a recent move to a different study design, enrolling patients who are already taking “stable ...
M. Maral Mouradian, A. Jon Stoessl, Anthony E. Lang   +2 more
wiley   +1 more source